Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,18,0.87 [0.8-0.94],0.000752461155713215,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,18,0.94 [0.9-0.98],0.00376298634037508,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,18,0.83 [0.73-0.95],0.00713064567006123,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,18,0.93 [0.88-0.98],0.00862602016042593,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,18,1.08 [1.02-1.15],0.0100388149823622,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,18,0.89 [0.81-0.98],0.015877936904529,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,18,0.91 [0.84-0.99],0.0322345243655786,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Inverse variance weighted,11,1.05 [1-1.09],0.0352852534002642,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,11,0.86 [0.74-0.99],0.0418281728538131,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,18,1.05 [1-1.11],0.043624017075071,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,18,1.14 [1-1.3],0.0457792155274379,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,18,0.89 [0.78-1],0.0565916866210239,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,18,0.85 [0.72-1.01],0.0620899838407302,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,18,0.93 [0.86-1],0.0638968870919344,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,18,1.11 [0.98-1.25],0.0901658868375601,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ITP,Inverse variance weighted,18,0.83 [0.67-1.03],0.0979530612848152,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Inverse variance weighted,11,0.91 [0.81-1.02],0.102888883656938,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,18,1.03 [0.99-1.07],0.104574619459083,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,18,1.02 [1-1.05],0.105661915514403,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Inverse variance weighted,11,1.02 [0.99-1.05],0.110560391415929,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,18,0.87 [0.74-1.03],0.115376692508427,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,18,1.03 [0.99-1.06],0.127983331995299,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,18,1.06 [0.98-1.16],0.144162998036995,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,18,0.96 [0.9-1.02],0.149468229456169,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_SKIN_SUBCUTAN,Inverse variance weighted,11,0.98 [0.95-1.01],0.162962270837417,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,11,0.97 [0.93-1.01],0.167961760159611,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,11,1.03 [0.99-1.07],0.176034916265488,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,18,0.89 [0.75-1.05],0.178457893998427,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,11,0.89 [0.76-1.05],0.179596494784553,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,11,1.02 [0.99-1.04],0.186024845467831,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,18,1.06 [0.97-1.17],0.18955912564732,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,18,1.07 [0.97-1.18],0.195223436395097,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Inverse variance weighted,11,0.95 [0.87-1.03],0.20201818834012,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,18,1.02 [0.99-1.06],0.218341827731188,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,18,0.99 [0.96-1.01],0.222547241333502,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,CD2_NONHODGKIN_NAS_EXALLC,Inverse variance weighted,18,1.12 [0.93-1.35],0.232127104697112,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,18,1.04 [0.97-1.11],0.240721382197315,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,18,1.03 [0.98-1.08],0.248993239841143,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,18,1.02 [0.99-1.05],0.252566962718429,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,18,0.95 [0.86-1.04],0.258906106180299,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,18,1.09 [0.94-1.27],0.266170072091955,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,18,1.02 [0.99-1.05],0.266534656145109,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,18,0.91 [0.77-1.08],0.268408605938107,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,18,1.04 [0.97-1.12],0.278341554729651,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,18,0.93 [0.82-1.06],0.279051713931754,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,18,1.06 [0.96-1.16],0.285049685235898,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,18,0.98 [0.93-1.02],0.307088519955912,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,18,1.04 [0.96-1.12],0.321778945598021,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,18,0.95 [0.85-1.05],0.323645738555833,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,11,0.94 [0.84-1.06],0.333864626592917,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,18,1.04 [0.96-1.12],0.350114538940803,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,18,0.82 [0.53-1.26],0.355545423376345,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,18,1.04 [0.95-1.14],0.367306562294496,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,11,1.02 [0.97-1.07],0.382749210062077,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,18,1.06 [0.93-1.2],0.38530532350867,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,18,0.98 [0.94-1.03],0.39204845082088,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,18,0.95 [0.84-1.07],0.40396702068779,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,18,0.88 [0.64-1.2],0.405579239369857,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,18,1.02 [0.98-1.06],0.416225940023405,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_EROSECTROPUT,Inverse variance weighted,18,0.93 [0.78-1.12],0.460844386322749,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,18,1.01 [0.98-1.04],0.46243134911933,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,18,1.05 [0.92-1.21],0.462772399812711,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,18,0.93 [0.75-1.14],0.465623781837818,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,18,1.01 [0.98-1.04],0.467480626923686,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,18,1.01 [0.99-1.03],0.472821850775403,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,18,1.01 [0.98-1.03],0.486348055861204,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,18,1.01 [0.98-1.04],0.50092399069521,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,18,1.02 [0.97-1.07],0.509692158588249,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Inverse variance weighted,11,1.02 [0.95-1.1],0.521671455733998,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,18,1.04 [0.92-1.18],0.521810974524783,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,11,0.99 [0.97-1.01],0.542762491850091,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,18,0.99 [0.96-1.02],0.581676547401559,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Inverse variance weighted,11,0.99 [0.93-1.04],0.587910093165192,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,18,0.97 [0.85-1.09],0.598216008202128,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,COLITNONINFNAS,Inverse variance weighted,11,0.99 [0.94-1.04],0.612597656897717,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,11,0.98 [0.89-1.07],0.620883574187074,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_GIDISEASES,Inverse variance weighted,11,0.99 [0.97-1.02],0.625813974166444,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,18,0.96 [0.81-1.14],0.627919320835609,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,18,1.01 [0.98-1.03],0.627939732068373,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,18,0.97 [0.84-1.11],0.64259784911617,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,18,1.04 [0.88-1.22],0.6470361095467,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Inverse variance weighted,11,1.01 [0.97-1.05],0.676701440392959,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,11,1.02 [0.93-1.12],0.681000391498067,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,18,1.01 [0.97-1.05],0.681502536923177,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,18,1.01 [0.98-1.04],0.689647089518801,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,18,1.02 [0.92-1.13],0.690041782419425,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,18,0.99 [0.94-1.05],0.69398209513925,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,18,1.05 [0.81-1.36],0.697334926550249,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,18,1.01 [0.97-1.04],0.698841504187777,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,18,1.01 [0.96-1.06],0.701441378937286,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,18,1 [0.98-1.03],0.713187727372139,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Inverse variance weighted,11,0.98 [0.86-1.11],0.720259242982195,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,18,1.02 [0.93-1.12],0.724191262217397,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,18,0.97 [0.83-1.14],0.738749397972904,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Inverse variance weighted,11,0.99 [0.95-1.04],0.747390986696837,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,11,0.98 [0.88-1.1],0.75226973154168,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,18,0.97 [0.76-1.23],0.782086299799948,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,18,1 [0.98-1.03],0.785829475611707,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,18,0.98 [0.86-1.12],0.788438196681103,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,18,1.01 [0.95-1.06],0.794593599800486,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,18,1.01 [0.93-1.1],0.810273008845219,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SLE,Inverse variance weighted,11,1.06 [0.66-1.7],0.814118403992072,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,18,1 [0.98-1.03],0.825140560771305,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Inverse variance weighted,11,1.03 [0.79-1.34],0.835176801716065,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Inverse variance weighted,11,1 [0.97-1.03],0.836721309816084,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,18,1.01 [0.95-1.07],0.844504230149828,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,18,1.01 [0.9-1.13],0.845893531633689,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,18,0.99 [0.92-1.07],0.85373474655968,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Inverse variance weighted,11,1.01 [0.89-1.16],0.860126129498358,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,18,0.99 [0.93-1.07],0.861797640171214,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,18,1.01 [0.91-1.12],0.864380731207472,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,CD2_NONFOLLICULAR_LYMPHOMA_EXALLC,Inverse variance weighted,18,0.99 [0.89-1.1],0.867816811156028,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,18,0.99 [0.92-1.08],0.872638218271337,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,18,1 [0.96-1.05],0.872661149113668,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,18,1 [0.95-1.07],0.872973879477759,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Inverse variance weighted,11,1 [0.97-1.03],0.893638450494719,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,18,1 [0.97-1.04],0.897600505444553,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,18,1 [0.97-1.03],0.90289600905141,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_WIDE,Inverse variance weighted,18,1 [0.95-1.06],0.913979160946217,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,18,1 [0.93-1.08],0.914118103981374,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,18,1 [0.96-1.04],0.91541482076026,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,18,1 [0.97-1.03],0.924581678000816,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Inverse variance weighted,11,1 [0.94-1.06],0.944238178030147,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,18,1 [0.96-1.04],0.950653549978827,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,18,0.99 [0.71-1.38],0.957931031976371,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,18,1 [0.9-1.11],0.962030863052052,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,18,1 [0.93-1.08],0.965056268290426,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_OTH,Inverse variance weighted,18,1 [0.95-1.06],0.971893367074361,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,18,1 [0.89-1.12],0.974351220412351,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,18,1 [0.92-1.1],0.9757765441433,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_MALABSORB,Inverse variance weighted,18,1 [0.86-1.16],0.979815261814446,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,18,1 [0.67-1.5],0.990793952085558,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,18,1 [0.88-1.13],0.991687382682029,cis
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,22,0.88 [0.81-0.95],0.00155965190524269,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,22,0.84 [0.74-0.95],0.00489147832899792,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,22,0.95 [0.91-0.99],0.00995300462352721,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,22,1.08 [1.02-1.15],0.0138881503820136,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,22,0.89 [0.82-0.98],0.0161619566658872,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,22,0.94 [0.89-0.99],0.0288972317486843,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,22,1.14 [1.01-1.29],0.0296623453372046,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,22,0.91 [0.84-0.99],0.0345019191281581,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,22,1.05 [1-1.1],0.0517423718602632,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,22,1.03 [1-1.05],0.0555340611624873,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,22,0.89 [0.79-1],0.0592948518908622,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,22,0.85 [0.73-1.01],0.0612744639792793,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,22,0.86 [0.73-1.01],0.0682513480904082,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,22,0.93 [0.86-1.01],0.0720802141303268,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,22,1.11 [0.99-1.25],0.0727659452916296,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,22,1.03 [1-1.07],0.0783612936416835,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,22,1.03 [1-1.06],0.0867742251136799,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ITP,Inverse variance weighted,22,0.85 [0.68-1.05],0.135931563913527,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,22,1.07 [0.98-1.18],0.141761377313162,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,22,1.03 [0.99-1.07],0.143470717553084,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,22,1.04 [0.98-1.11],0.186977965520702,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,22,1.06 [0.97-1.15],0.194434615961003,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,22,1.04 [0.98-1.11],0.194676737721606,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,22,1.02 [0.99-1.05],0.19553200375294,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,22,1.06 [0.97-1.16],0.196641181321292,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,CD2_NONHODGKIN_NAS_EXALLC,Inverse variance weighted,22,1.13 [0.94-1.37],0.19701475207216,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,22,1.1 [0.95-1.26],0.198791236426839,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,22,0.96 [0.91-1.02],0.214182772529986,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,22,0.94 [0.84-1.04],0.230822301374222,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,22,1.02 [0.99-1.05],0.232556528061356,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,22,0.95 [0.88-1.03],0.234194164001192,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,22,0.91 [0.77-1.07],0.239512974140165,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,22,1.04 [0.97-1.12],0.244866425869127,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1.03 [0.98-1.09],0.271620972956918,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,22,0.98 [0.94-1.02],0.280318132972694,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,22,1.06 [0.96-1.17],0.287815692308696,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,22,0.92 [0.78-1.08],0.298893973725709,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,22,0.8 [0.52-1.22],0.303877276312609,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,22,0.9 [0.74-1.1],0.312659677302888,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,22,0.94 [0.82-1.07],0.326399419268915,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,22,1.01 [0.98-1.04],0.355080001988747,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,22,0.94 [0.84-1.07],0.359450182238944,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,22,1.03 [0.96-1.11],0.364324535120926,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,22,0.87 [0.64-1.19],0.377786248737412,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,22,1.04 [0.95-1.14],0.381181798601342,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,22,0.98 [0.94-1.02],0.386329283377456,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,22,1.05 [0.93-1.19],0.411334043932516,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,22,1.02 [0.97-1.07],0.424475802084867,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,22,1.01 [0.98-1.04],0.431001057203741,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,22,0.99 [0.95-1.02],0.432497937621346,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,22,1.01 [0.99-1.03],0.484719441661731,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,22,1.02 [0.97-1.07],0.487530264742918,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,22,1.05 [0.92-1.2],0.488568012718005,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,22,1.04 [0.92-1.18],0.489881974045358,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,22,1.04 [0.94-1.15],0.491597309423536,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_EROSECTROPUT,Inverse variance weighted,22,0.94 [0.78-1.13],0.502659510284277,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,22,1.01 [0.98-1.03],0.523195601304556,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,22,1.01 [0.97-1.05],0.567902821591904,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,22,1.01 [0.98-1.04],0.569405596096624,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,22,0.97 [0.87-1.08],0.598148660780411,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,22,1.02 [0.94-1.11],0.604199368675169,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,22,1.01 [0.96-1.07],0.617834038058778,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,22,0.99 [0.96-1.02],0.63030702136623,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,22,1.01 [0.98-1.03],0.642881624437108,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,22,0.95 [0.75-1.21],0.675033425874536,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,22,1.03 [0.88-1.21],0.679723581092667,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,22,1.01 [0.98-1.03],0.69761107316602,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,22,1.05 [0.81-1.35],0.70668031208704,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,22,0.98 [0.86-1.1],0.714373054721281,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,22,1.01 [0.95-1.07],0.720448512544926,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,22,1.01 [0.93-1.11],0.748052174089511,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,22,1.01 [0.96-1.06],0.801199609760198,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,22,0.98 [0.86-1.13],0.805776651433077,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,22,1.01 [0.95-1.07],0.807710132504038,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,22,0.98 [0.82-1.17],0.818140404633102,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_WIDE,Inverse variance weighted,22,1.01 [0.94-1.08],0.830552687604598,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,22,1.01 [0.9-1.14],0.832281957494033,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,22,0.99 [0.92-1.07],0.838338029980291,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,22,0.97 [0.7-1.34],0.846116306964471,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,22,1 [0.95-1.06],0.857085010886367,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,22,1.01 [0.9-1.14],0.865036464156834,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,22,1 [0.98-1.03],0.869570776700824,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,22,1 [0.94-1.05],0.869832811488795,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,22,1.01 [0.9-1.13],0.872684466551429,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_SEROPOS_OTH,Inverse variance weighted,22,1 [0.94-1.08],0.891418321501006,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,22,1 [0.97-1.04],0.894669626364554,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,K11_MALABSORB,Inverse variance weighted,22,0.99 [0.84-1.17],0.895370027257202,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,22,1.01 [0.91-1.12],0.895390764979701,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,22,1 [0.94-1.07],0.89707602976948,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,22,0.99 [0.85-1.16],0.897215874893,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,22,1 [0.97-1.04],0.901722536321708,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,22,1.01 [0.91-1.12],0.907734920363125,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,22,1 [0.97-1.03],0.90817040475754,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,22,0.98 [0.66-1.45],0.91472655131947,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,22,1 [0.93-1.09],0.920100436843477,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,22,1 [0.97-1.04],0.928570013238297,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,22,1 [0.93-1.08],0.934113171050593,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,22,1 [0.98-1.03],0.946113143202575,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,22,1 [0.97-1.03],0.954772137347584,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,22,1 [0.96-1.04],0.96061878694962,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,22,1 [0.93-1.07],0.975147742878455,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,22,1 [0.96-1.04],0.975643604267735,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,22,1 [0.92-1.09],0.988256985017717,trans
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,CD2_NONFOLLICULAR_LYMPHOMA_EXALLC,Inverse variance weighted,22,1 [0.9-1.11],0.992078600553198,trans
